Group One Trading, L.P. X Biotech Inc. Transaction History

Group One Trading, L.P.

$2.4 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$4.02 - $5.81 $6,319 - $9,133	1,572 Added 946.99%	1,738 $7,000
Q2 2023 Aug 09, 2023	BUY	$3.06 - $6.38 $507 - $1,059	166 New	166 $0
Q2 2022 Aug 11, 2022	BUY	$5.13 - $9.2 $17,955 - $32,199	3,500 Added 700.0%	4,000 $23,000
Q1 2022 May 12, 2022	BUY	$8.64 - $11.71 $4,320 - $5,855	500 New	500 $4,000
Q4 2021 Feb 11, 2022	SELL	$10.95 - $16.07 $22,162 - $32,525	-2,024 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$12.95 - $18.24 $26,210 - $36,917	2,024 New	2,024 $26,000
Q2 2021 Aug 10, 2021	SELL	$15.83 - $17.84 $205,774 - $231,902	-12,999 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$15.92 - $20.3 $115,101 - $146,769	-7,230 Reduced 35.74%	12,999 $223,000
Q4 2020 Feb 10, 2021	SELL	$15.65 - $19.92 $71,990 - $91,632	-4,600 Reduced 18.53%	20,229 $317,000
Q3 2020 Nov 12, 2020	BUY	$13.97 - $21.16 $32,592 - $49,366	2,333 Added 10.37%	24,829 $474,000
Q2 2020 Aug 13, 2020	BUY	$10.39 - $16.07 $97,375 - $150,608	9,372 Added 71.41%	22,496 $308,000
Q1 2020 May 13, 2020	BUY	$8.89 - $24.94 $110,351 - $309,580	12,413 Added 1745.85%	13,124 $139,000
Q4 2019 Feb 10, 2020	SELL	$8.33 - $19.95 $101,542 - $243,190	-12,190 Reduced 94.49%	711 $13,000
Q3 2019 Nov 12, 2019	BUY	$6.86 - $10.46 $43,869 - $66,891	6,395 Added 98.29%	12,901 $135,000
Q2 2019 Aug 09, 2019	BUY	$6.99 - $11.27 $15,405 - $24,839	2,204 Added 51.23%	6,506 $49,000
Q1 2019 May 13, 2019	SELL	$5.05 - $11.62 $70,846 - $163,016	-14,029 Reduced 76.53%	4,302 $47,000
Q4 2018 Feb 06, 2019	BUY	$3.22 - $6.27 $3,928 - $7,649	1,220 Added 7.13%	18,331 $93,000
Q3 2018 Nov 08, 2018	SELL	$2.31 - $4.69 $27,791 - $56,425	-12,031 Reduced 41.28%	17,111 $54,000
Q2 2018 Aug 14, 2018	BUY	$4.04 - $5.13 $54,043 - $68,624	13,377 Added 84.85%	29,142 $131,000
Q1 2018 May 11, 2018	SELL	$3.92 - $5.35 $25,872 - $35,310	-6,600 Reduced 29.51%	15,765 $84,000
Q4 2017 Feb 09, 2018	SELL	$3.9 - $4.66 $103,763 - $123,983	-26,606 Reduced 54.33%	22,365 $88,000
Q3 2017 Nov 15, 2017	BUY	$4.14 - $5.12 $167,222 - $206,807	40,392 Added 470.82%	48,971 $214,000
Q2 2017 Aug 14, 2017	BUY	N/A	8,579	8,579 $40,000

Others Institutions Holding XBIT

# of Institutions

Shares Held

4.87M

Call Options Held

Put Options Held

Black Rock Inc. New York, NY

1.13M
Shares

$4.4 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

1.06M
Shares

$4.12 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

452K
Shares

$1.75 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

281K
Shares

$1.09 Million
0.0% of portfolio
Ubs Asset Management Americas Inc Chicago, IL

254K
Shares

$984,627
0.0% of portfolio

View Full List

About XBiotech Inc.

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $118M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

More about XBIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account